Lung Cancer Screening

Size: px
Start display at page:

Download "Lung Cancer Screening"

Transcription

1 Lung Cancer Screening Preston Wright, DO University of Kansas School of Medicine- Wichita Family Medicine Residency at Via Christi Hospitals 1

2 Objectives Identify patients who need screened for lung cancer Explain benefits and risks of lung cancer screening Summarize treatment recommendations 2

3 Case 68 year old male with a history of tobacco use disorder and CAD comes to the office for smoking cessation counseling Patient states that he has a friend with lung cancer who used to smoke and he wonders if he is at risk and what he can do to prevent lung cancer You discuss smoking cessation and through his history you note that he has an on and off history of 36 pack years and is currently smoking Besides sometimes having a cough he denies ever having other concerning symptoms such as hemoptysis, chest pain, or dyspnea Otherwise he is in generally good health 3

4 Why Screen Lung Cancer Leading cause of cancer deaths [1] 1.6 million deaths worldwide annually [2] 250,000 new U.S. cases each year Treating early more beneficial [3] 4

5 Who to Screen By the book: USPSTF 2013 Systematic Review [4] 55-80yo 30 pack years of smoking Currently smoking or quite not longer than 15years ago Generally good health Others National Comprehensive Cancer Network [5] 55-74yo Medicare [6] 55-77yo 5

6 Screening Basis NLST (National Lung Cancer Screening Trial) [4] RCT 53,000 patients; CT vs. CXR 55-74yo Followed annually for 6.5yrs Positive= non-calcified nodule >4mm Positive Results: NN to screen 1:320 Cancer mortality benefit 20% All cause mortality benefit 6.7% 6

7 Benefits of Screening Stats Cancer mortality [4] All-cause mortality [4] Earlier detection [3] Best smoking cessation [3] 7

8 Harms of Screening False Positives Patient Distress Unnecessary Interventions Incidental Findings Radiation 8

9 Harms of Screening False Positives NLST: 24.2% positive LDCT [4] 96% were false positive 11% of positive led to invasive study Veterans home: 59.7% Positive [7] 1.5% truly had cancer. 1:17 may have had it, 1:42 actually had it 40% positive screen require follow up imaging Patient distress 9

10 Harms of Screening Radiation exposure [8] LDCT 1.4mSv vs. Standard CT 7-8mSv Cumulative13.0mSv For every 108 cancers discovered one was induced Overdiagnosis [9] 13-27% per observational studies 10

11 Evaluating the Data Who is it most effective in? [10] Current smokers in their 60 s Cost per quality life year [10] Modeling Cost Effectiveness Study; NEJM 2014 $52,000 per life year $81,000 per quality adjusted life year gain 60-69yo: most cost effective Cost of CT affect cost quality 11

12 Coding ICD-10 [6] Z Personal Hx of nicotine dependence CPT codes G Counseling visit to discuss need for lung cancer screening using low dose CT scan G0297 Low-dose CT scan for lung cancer screening Age 55-77yo [6] 12

13 Case Revisited 68 year old male with a history of tobacco use disorder and CAD comes to the office for smoking cessation counseling Patient states that he has a friend with lung cancer who used to smoke and he wonders if he is at risk and what he can do to prevent lung cancer You discuss smoking cessation and through his history you note that he has an on and off history of 36 pack years and is currently smoking Besides sometimes having a cough he denies ever having other symptoms hemoptysis, chest pain, or dyspnea Otherwise he is in generally good health 13

14 References 1. Siegel RL, Miller KD, Jemel A. Cancer statistics, 2017, CA Camcer J Clin 2017; 67: 7 2. Stewart B, Wild CP. World Cancer Report 2014, van der Aalst CM, van der Bergh Kaa, Willemsen MC, et al. Lung cancer screening and smoking abstinence: 2 year follow up data from the Dutch Belgian randomized controlled Lung Cancer Screening Trial. Thorax 2010; 65: National Lung Screening Trial Research Team, Aberle BR, Adams AM, et al. Reduced lung-cancer mortality with low dose computed tomographic screening N Engl J Med 2011, 365: Wood DE, National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines for Lunc Cancer Screening. Thoracic Surg Clin 2015; 25: Hughes, Cindy. How to Document and Code Medicare Preventative Services. Family Practice Management Jul-Aug;23(4): Kisinger LS, Anderson c. Kim J, et al. Implementation of lung cancer screening in the Veterans Health Administration. JAMA Intern Med 2017; 177: Larke FJ, Kruger RL, Cagnon CH, et al. Estimated radiation dose associated with low dose chet CT of averagesize participants in the National Lung Screening Trial. AJR Ana J Roentgenol. 2011; 197: Reich JM. A critical appraisal of overdiagnosis: estimates of its magnitude and implications of lunc cancer screening. Thorax 2008; 63: Black WC, Gareen IF, Soneji SS, et al. Cost-effectiveness of CT screening in the National Lung Screening Trial. N Engl J Med 2014; 371: Other: Essential Evidence Plus. POEM of the Week. 14

15 Thank you. ANY QUESTIONS? 15

Lung Cancer Screening. Eric S. Papierniak, DO NF/SG VHA UF Health

Lung Cancer Screening. Eric S. Papierniak, DO NF/SG VHA UF Health Lung Cancer Screening Eric S. Papierniak, DO NF/SG VHA UF Health Overview Background Supporting evidence Guidelines Practical considerations Patient selection What to do with abnormal results Billing/coding

More information

Lung Cancer Screening: To screen or not to screen?

Lung Cancer Screening: To screen or not to screen? Lung Cancer Screening: To screen or not to screen? Dan J. Raz, M.D. Co Director, Lung Cancer Screening Program Co Director, LungCancer and Thoracic OncologyProgram Assistant Professor, Thoracic Surgery

More information

LUNG CANCER: LDCT DISCLOSURES NONE. Erika Swanson, MD Radiation Oncologist Ascension Columbia-St. Mary s February 1, /9/2018

LUNG CANCER: LDCT DISCLOSURES NONE. Erika Swanson, MD Radiation Oncologist Ascension Columbia-St. Mary s February 1, /9/2018 LUNG CANCER: LDCT Erika Swanson, MD Radiation Oncologist Ascension Columbia-St. Mary s February 1, 2018 DISCLOSURES 2 NONE 1 OBJECTIVES 3 Rationale and evidence for LDCT for lung cancer screening Review

More information

Disclosures. Overview. Selection the most accurate statement: Updates in Lung Cancer Screening 5/26/17. No Financial Disclosures

Disclosures. Overview. Selection the most accurate statement: Updates in Lung Cancer Screening 5/26/17. No Financial Disclosures Updates in Lung Cancer Screening Disclosures No Financial Disclosures Neil Trivedi, MD Associate Professor of Clinical Medicine SF VAMC Pulmonary and Critical Care Director, Bronchoscopy & Interventional

More information

LUNG CANCER SCREENING

LUNG CANCER SCREENING LUNG CANCER SCREENING Christopher Lettieri MD, FACP, FCCP, FAASM Pulmonary/Critical Care Consultant to the Surgeon General Professor of Medicine Walter Reed National Military Medical Center American College

More information

Lung Cancer Screening: Benefits and limitations to its Implementation

Lung Cancer Screening: Benefits and limitations to its Implementation Lung Cancer Screening: Benefits and limitations to its Implementation Rolando Sanchez, MD Clinical Assistant Professor Pulmonary-Critical Care Medicine University of Iowa Lung cancer - Epidemiology Cancer

More information

Lung Cancer Screening

Lung Cancer Screening Lung Cancer Screening Steven Leh, MD, FCCP Diplomat of the American Association for Bronchology and Interventional Pulmonology Aurora Medical Group Pulmonary and Sleep Medicine February 10, 2018 Disclosures

More information

Lung cancer screening in Switzerland

Lung cancer screening in Switzerland SAMO Interdisciplinary Workshop on Chest Tumors 27 th and 28 th January 2017 Hotel Hermitage, Lucerne Lung cancer screening in Switzerland Walter Weder, MD, Professor of Surgery University Hospital Zurich,

More information

Ann Intern Med. 2012;156(5):

Ann Intern Med. 2012;156(5): Lung Cancer Screening Update Doug Arenberg, M.D. University of Michigan Outline Screening; Some simple but necessary truths Do people benefit from screening? What are the harms (and are they outweighed

More information

Goals of Presentation

Goals of Presentation Goals of Presentation Review context of lung cancer screening why is it important? Review data from NLST supporting screening with lowdose CT (LDCT) scanning Discuss the pros and cons of LDCT screening

More information

A Comprehensive Cancer Center Designated by the National Cancer Institute

A Comprehensive Cancer Center Designated by the National Cancer Institute N C I C C C A Comprehensive Cancer Center Designated by the National Cancer Institute Screening and Early Detection of Lung Cancer: Ready for Practice? David S. Ettinger, MD, FACP, FCCP Alex Grass Professor

More information

DISCLOSURE. Lung Cancer Screening: The End of the Beginning. Learning Objectives. Relevant Financial Relationship(s) Off Label Usage

DISCLOSURE. Lung Cancer Screening: The End of the Beginning. Learning Objectives. Relevant Financial Relationship(s) Off Label Usage Peninsula Regional Medical Center 12 th Annual Lung Cancer Conference March 9, 2017 Lung Cancer Screening: The End of the Beginning David E. Midthun M.D. Professor of Medicine College of Medicine, Mayo

More information

Lung Cancer Screening: To Screen or Not to Screen?

Lung Cancer Screening: To Screen or Not to Screen? Lung Cancer Screening: To Screen or Not to Screen? Lorriana Leard, MD Co-Director of UCSF Lung Cancer Screening Program Vice Chief of Clinical Activities UCSF Pulmonary, Critical Care, Allergy & Sleep

More information

Lung cancer screening: appropriate pa0ent selec0on and informed decision making

Lung cancer screening: appropriate pa0ent selec0on and informed decision making Lung cancer screening: appropriate pa0ent selec0on and informed decision making William C. Black, MD Department of Radiology Norris Co@on Cancer Center Geisel School of Medicine at Dartmouth Dartmouth-

More information

CT Screening for Lung Cancer for High Risk Patients

CT Screening for Lung Cancer for High Risk Patients CT Screening for Lung Cancer for High Risk Patients The recently published National Lung Cancer Screening Trial (NLST) showed that low-dose CT screening for lung cancer reduces mortality in high-risk patients

More information

SCREENING FOR EARLY LUNG CANCER. Pang Yong Kek

SCREENING FOR EARLY LUNG CANCER. Pang Yong Kek SCREENING FOR EARLY LUNG CANCER Pang Yong Kek Lecture Outline Why performing screening? How to improve early detection? Benefits and Risks of screening Challenges in screening Conclusion Why Performing

More information

Lung Cancer screening :

Lung Cancer screening : Lung Cancer screening : Pro-Contra SAMO interdisciplinary workshop on chest tumors 27 and 28 january 2017 Prof L.P.Nicod Sevice de pneumologie CHUV-Lausanne -CH Lung Cancer How big is the problem? Epidemiology

More information

LUNG CANCER SCREENING WHAT S THE IMPACT? Nitra Piyavisetpat, MD Department of Radiology Chulalongkorn University

LUNG CANCER SCREENING WHAT S THE IMPACT? Nitra Piyavisetpat, MD Department of Radiology Chulalongkorn University LUNG CANCER SCREENING WHAT S THE IMPACT? Nitra Piyavisetpat, MD Department of Radiology Chulalongkorn University Objective LDCT lung cancer screening (LCS) Potential Benefits & Harms Recommendation of

More information

A Summary from the 2013World Conference on Lung Cancer Sydney, Australia

A Summary from the 2013World Conference on Lung Cancer Sydney, Australia A Summary from the 2013World Conference on Lung Cancer Sydney, Australia In 2011, the U.S. National Lung Screening Trial (NLST) has demonstrated that low-dose computed tomography (LDCT) screening of high

More information

Harnessing the Power of the DNP: Leading the Development and Implementation of an Evidence Based Clinical Program JOELLE FATHI, DNP, RN, ARNP, CTTS

Harnessing the Power of the DNP: Leading the Development and Implementation of an Evidence Based Clinical Program JOELLE FATHI, DNP, RN, ARNP, CTTS Harnessing the Power of the DNP: Leading the Development and Implementation of an Evidence Based Clinical Program JOELLE FATHI, DNP, RN, ARNP, CTTS Objectives Identify innovative ways in which the DNP

More information

Tobacco Use among VA Patients Receiving Lung Cancer Screening: Cessation at 1 year Post Screening

Tobacco Use among VA Patients Receiving Lung Cancer Screening: Cessation at 1 year Post Screening Tobacco Use among VA Patients Receiving Lung Cancer Screening: Cessation at 1 year Post Screening Zeliadt SB, Krebs P, Johnson H, Feemster LC, Klein D, Crothers K, Au D, Heffner J Presented by Paul Krebs,

More information

An Update on Lung Cancer Screening Policy and the Role of Quitlines

An Update on Lung Cancer Screening Policy and the Role of Quitlines An Update on Lung Cancer Screening Policy and the Role of Quitlines Robert J. Volk, PhD Vance Rabius, PhD The University of Texas MD Anderson Cancer Center North American Quitline Consortium NAQC Conference

More information

Lung Cancer Screening: Radiologic and Clinical Implications. Katherine R. Birchard, M.D. University of North Carolina at Chapel Hill

Lung Cancer Screening: Radiologic and Clinical Implications. Katherine R. Birchard, M.D. University of North Carolina at Chapel Hill Lung Cancer Screening: Radiologic and Clinical Implications Katherine R. Birchard, M.D. University of North Carolina at Chapel Hill Nothing to disclose Objectives In context of NLST: Review Imaging Techniques

More information

CT screening for lung cancer. Should it be done in the Indian context?

CT screening for lung cancer. Should it be done in the Indian context? CT screening for lung cancer Should it be done in the Indian context? Wilson and Jungner screening criteria 1. The condition sought should be an important health problem. 2. There should be an accepted

More information

Screening Programs background and clinical implementation. Denise R. Aberle, MD Professor of Radiology and Engineering

Screening Programs background and clinical implementation. Denise R. Aberle, MD Professor of Radiology and Engineering Screening Programs background and clinical implementation Denise R. Aberle, MD Professor of Radiology and Engineering disclosures I have no disclosures. I have no conflicts of interest relevant to this

More information

LDCT Screening. Steven Kirtland, MD. Virginia Mason Medical Center February 27, 2015

LDCT Screening. Steven Kirtland, MD. Virginia Mason Medical Center February 27, 2015 LDCT Screening Steven Kirtland, MD Virginia Mason Medical Center February 27, 2015 2 Disclosures 4 5 Cancer Screening Mrs H 64yo 50 pk year smoker Lung Cancer Epidemiology Leading Cause of Cancer Death

More information

Christine Argento, MD Interventional Pulmonology Emory University

Christine Argento, MD Interventional Pulmonology Emory University Christine Argento, MD Interventional Pulmonology Emory University Outline Lung Cancer Statistics Prior Studies for Lung Cancer Screening NLST Studies Following NLST Future Directions Lung Cancer American

More information

LUNG CANCER SCREENING: LUNG CANCER SCREENING: THE TIME HAS COME LUNG CANCER: A NATIONAL EPIDEMIC

LUNG CANCER SCREENING: LUNG CANCER SCREENING: THE TIME HAS COME LUNG CANCER: A NATIONAL EPIDEMIC : THE TIME HAS COME Physician Leader, Lung Cancer Multi-Disciplinary Program Fletcher Allen Health Care Annual Meeting Montpelier, VT - April 25, 2014 Gerald S. Davis, MD Professor of Medicine University

More information

Objectives. Why? Why? Background 11/5/ % incurable disease at presentation Locally advanced disease Metastasis. 14% 5 year survival

Objectives. Why? Why? Background 11/5/ % incurable disease at presentation Locally advanced disease Metastasis. 14% 5 year survival Objectives Appraise lung cancer screening trials results Review screening guidelines Lung Cancer Screening: Past, Present and Future Chi Wan Koo, MD Koo.chiwan@mayo.edu Discuss recommendations essential

More information

American Medical Association Journal of Ethics

American Medical Association Journal of Ethics American Medical Association Journal of Ethics July 2015, Volume 17, Number 7: 601-607 ETHICS CASE Close-Call Screening and Shared Decision Making Commentary by Evelyn Chan, MD, MS Dr. Samuelson is an

More information

Example of lung screening

Example of lung screening Justification of the use of CT for individual health assessment of asymptomatic people How to obtain evidence for IHA - Example of lung screening Mathias Prokop, MD PhD Professor of Radiology Radboud University

More information

Lung Cancer Screening Benefits, Risks & Challenges

Lung Cancer Screening Benefits, Risks & Challenges Lung Cancer Screening Benefits, Risks & Challenges Polly Sather, APRN Yale Lung Screening and Nodule Program (Yale Lung SCAN) A Multidisciplinary Comprehensive Initiative Yale Cancer Center Thoracic Oncology

More information

Lung Cancer Screening Trials. Edward Harris Respiratory Research Fellow Sir Charles Gairdner Hospital

Lung Cancer Screening Trials. Edward Harris Respiratory Research Fellow Sir Charles Gairdner Hospital Lung Cancer Screening Trials Edward Harris Respiratory Research Fellow Sir Charles Gairdner Hospital Lung Cancer Screening in Australia Not Funded except as part of a clinical trial Rationale PLCO, ELCAP

More information

Lung Cancer Screening Computed Tomography Screening in Pa6ents at Risk for Lung Cancer

Lung Cancer Screening Computed Tomography Screening in Pa6ents at Risk for Lung Cancer Lung Cancer Screening Computed Tomography Screening in Pa6ents at Risk for Lung Cancer Doug Arenberg, M.D. University of Michigan Disclosures Objec6ve Define patients who will benefit from screening for

More information

The complex, intertwined role of patients in research and care

The complex, intertwined role of patients in research and care Session 3: The complex, intertwined role of patients in research and care Joseph Chin, MD, MS, Acting Deputy Director, Coverage and Analysis Group, Centers for Medicare & Medicaid Services The complex,

More information

MEDICAL POLICY SUBJECT: LOW-DOSE COMPUTED TOMOGRAPHY (LDCT) FOR LUNG CANCER SCREENING. POLICY NUMBER: CATEGORY: Technology Assessment

MEDICAL POLICY SUBJECT: LOW-DOSE COMPUTED TOMOGRAPHY (LDCT) FOR LUNG CANCER SCREENING. POLICY NUMBER: CATEGORY: Technology Assessment MEDICAL POLICY SUBJECT: LOW-DOSE COMPUTED CANCER SCREENING 05/18/05, 03/16/06, 12/21/06, 08/16/07, PAGE: 1 OF: 6 If a product excludes coverage for a service, it is not covered, and medical policy criteria

More information

Professor John K Field PhD, FRCPath University of Liverpool Cancer Research Centre, UK.

Professor John K Field PhD, FRCPath University of Liverpool Cancer Research Centre, UK. Professor John K Field PhD, FRCPath University of Liverpool Cancer Research Centre, UK. J.K.Field@liv.ac.uk 1.8 million new cases in 2012 Bender Nature Outlook 2014 Probability of survival: ALL participants

More information

Lung Cancer Screening

Lung Cancer Screening Scan for mobile link. Lung Cancer Screening What is lung cancer screening? Screening examinations are tests performed to find disease before symptoms begin. The goal of screening is to detect disease at

More information

Screening for Lung Cancer - State of the Art

Screening for Lung Cancer - State of the Art Screening for Lung Cancer - State of the Art Rohit Kumar, MD Assistant Professor of Medicine Fox Chase Cancer Center Temple University School of Medicine Philadelphia, PA Objectives Review current evidence

More information

Lung Cancer Screening: Evidence and current recommendations

Lung Cancer Screening: Evidence and current recommendations Lung Cancer Screening: Evidence and current recommendations 20 th March 2018 Dr Annette McWilliams Fiona Stanley Hospital University of Western Australia WA Cancer & Palliative Care Network I have no financial

More information

Page 1. Cancer Screening for Women I have no conflicts of interest. Overview. Breast, Colon, and Lung Cancer. Jeffrey A.

Page 1. Cancer Screening for Women I have no conflicts of interest. Overview. Breast, Colon, and Lung Cancer. Jeffrey A. Cancer Screening for Women 2017 Breast, Colon, and Lung Cancer Jeffrey A. Tice, MD Professor of Medicine Division of General Internal Medicine University of California, San Francisco I have no conflicts

More information

LUNG CANCER SCREENING: ON WHOM DID YOU DO IT AND ON WHOM DO YOU RESPOND TO THE RESULTS?

LUNG CANCER SCREENING: ON WHOM DID YOU DO IT AND ON WHOM DO YOU RESPOND TO THE RESULTS? LUNG CANCER SCREENING: ON WHOM DID YOU DO IT AND ON WHOM DO YOU RESPOND TO THE RESULTS? DAVID O. WILSON, MD, MHP DIRECTOR GEORGIA COOPER MEMORIAL LUNG CANCER RESEARCH REGISTRY UNIVERSITY OF PITTSBURGH

More information

IEHP UM Subcommittee Approved Authorization Guidelines CT Screening (Low Dose) for Lung Cancer

IEHP UM Subcommittee Approved Authorization Guidelines CT Screening (Low Dose) for Lung Cancer CT Screening (Low Dose) for Lung Cancer Policy: There is currently adequate evidence that using low dose computed tomography (LDCT) to screen asymptomatic individuals who are at risk for lung cancer improves

More information

VHA Demonstration Project for Lung Cancer Screening Using Low-Dose Chest CT Screening

VHA Demonstration Project for Lung Cancer Screening Using Low-Dose Chest CT Screening VHA Demonstration Project for Lung Cancer Screening Using Low-Dose Chest CT Screening ATS San Francisco 2016 James K. Brown MD 1, Kathryn L. Rice, MD 2 (1) San Francisco VA (2) Minneapolis VAMC Disclosures

More information

Lung Cancer Screening

Lung Cancer Screening Scan for mobile link. Lung Cancer Screening What is lung cancer screening? Screening examinations are tests performed to find disease before symptoms begin. The goal of screening is to detect disease at

More information

Lung Cancer Screening. Ashish Maskey MD Interventional Pulmonology UK Health Care Dec 1 st 2017

Lung Cancer Screening. Ashish Maskey MD Interventional Pulmonology UK Health Care Dec 1 st 2017 Lung Cancer Screening Ashish Maskey MD Interventional Pulmonology UK Health Care Dec 1 st 2017 Nearly one in six American adults currently smoke cigarettes An estimated 40 million adults in the United

More information

Choosing Wisely. Objectives. Payal Sen PGY 1 Internal Medicine Residency Program University of New Mexico

Choosing Wisely. Objectives. Payal Sen PGY 1 Internal Medicine Residency Program University of New Mexico Choosing Wisely Payal Sen PGY 1 Internal Medicine Residency Program University of New Mexico Financial Disclosure I have no relationships with any entity producing, marketing, reselling or distributing,

More information

SHARED DECISION MAKING AND LUNG CANCER SCREENING

SHARED DECISION MAKING AND LUNG CANCER SCREENING SHARED DECISION MAKING AND LUNG CANCER SCREENING DISCLOSURES Cathleen E. Morrow, MD None William C. Black, MD No financial disclosure Co-investigator for NLST Member of the ACR Lung-RADS Screening Registry

More information

Outcomes in the NLST. Health system infrastructure needs to implement screening

Outcomes in the NLST. Health system infrastructure needs to implement screening Outcomes in the NLST Health system infrastructure needs to implement screening Denise R. Aberle, MD Professor of Radiology and Bioengineering David Geffen School of Medicine at UCLA 1 Disclosures I have

More information

Pulmonologist s Perspective

Pulmonologist s Perspective Low-dose CT for lung cancer screening Pulmonologist s Perspective Literature Review Kang-Yun Lee, MD PhD Department of Thoracic Medicine Taipei Medical University- Shuang Ho Hospital Taiwan Local vs. Advanced

More information

What to know and what to make of it

What to know and what to make of it Lung Cancer Screening: What to know and what to make of it J. Matthew Reinersman, MD Assistant Professor of Surgery Division of Thoracic and Cardiovascular Surgery Department of Surgery University of Oklahoma

More information

Lung Cancer Screening: Current Status

Lung Cancer Screening: Current Status Lung Cancer Screening: Current Status I have no financial relationships, arrangements or affiliations and this presentation will not include discussion of investigational or off-label use of a product

More information

Lung Cancer and CT Screening

Lung Cancer and CT Screening Lung Cancer and CT Screening Samer Kanaan, MD February 17 th, 2012 Goals Understand the Societal impact of Lung Cancer Identify Risk Factors for Lung Cancer List Diagnostic Tests Available for Lung Cancer

More information

Criteria USPSTF CMS. Frequency Annual screening Annual screening. No signs or symptoms of lung cancer

Criteria USPSTF CMS. Frequency Annual screening Annual screening. No signs or symptoms of lung cancer Lung Cancer Screening Guidelines with low- dose computed tomography (LDCT): USPSTF and CMS February 6, 2015 Kentucky Cancer Consortium and Kentucky LEADS Component 3 Jennifer Redmond Knight, DrPH, jredknight@kycancerc.org

More information

Smoking Cessation A Clinicians Perspective. Jeff Wilson, MD

Smoking Cessation A Clinicians Perspective. Jeff Wilson, MD Smoking Cessation A Clinicians Perspective Jeff Wilson, MD Overview Tobacco control what we have accomplished and the road ahead Role of the health care professional Using pharmacotherapy Electronic cigarettes

More information

Subject: Low-Dose Helical (Spiral) Computed Tomography for Lung Cancer Screening Guidance Number: MCG-137 Revision Date(s): 5/13/2015

Subject: Low-Dose Helical (Spiral) Computed Tomography for Lung Cancer Screening Guidance Number: MCG-137 Revision Date(s): 5/13/2015 Subject: Low-Dose Helical (Spiral) Computed Tomography for Lung Cancer Screening Guidance Number: MCG-137 Revision Date(s): 5/13/2015 Original Effective Date: 6/26/2013 DESCRIPTION OF PROCEDURE/SERVICE/PHARMACEUTICAL

More information

10/17/16. Lung Cancer Screening. Question 1: Does lung cancer screening make sense? 3rd lung cancer third most prevalent tumor type

10/17/16. Lung Cancer Screening. Question 1: Does lung cancer screening make sense? 3rd lung cancer third most prevalent tumor type Lung Cancer Screening Greg Rogalski Mercy Radiology Group greg@grogo.org Question 1: Does lung cancer screening make sense? 2 Requirements for successful screening process Sufficiently high prevalence

More information

Pulmonary Nodules. Michael Morris, MD

Pulmonary Nodules. Michael Morris, MD Pulmonary Nodules Michael Morris, MD Case 45 year old healthy male Smokes socially Normal physical exam Pre-employment screening remote +PPD screening CXR nodular opacity Case 45 year old healthy male

More information

Tobacco cessation in lung cancer screening do we have the evidence?

Tobacco cessation in lung cancer screening do we have the evidence? Editorial Tobacco cessation in lung cancer screening do we have the evidence? Emily Stone 1, Henry Marshall 2 1 Department of Thoracic Medicine and Kinghorn Cancer Centre, St Vincent s Hospital Sydney,

More information

SHARED DECISION MAKING IN MEDICARE COVERAGE

SHARED DECISION MAKING IN MEDICARE COVERAGE SHARED DECISION MAKING IN MEDICARE COVERAGE Kate Goodrich, MD MHS Director, Center for Clinical Standards and Quality CMS April 2, 2016 Disclaimer: Views and comments in this presentation are those of

More information

LUNG CANCER SCREENING COVERAGE IN STATE MEDICAID PROGRAMS

LUNG CANCER SCREENING COVERAGE IN STATE MEDICAID PROGRAMS LUNG CANCER SCREENING COVERAGE IN STATE MEDICAID PROGRAMS Overview Lung cancer is the leading cancer killer among both women and men. Early detection is critical to fighting lung cancer, and low-dose computed

More information

Lung Cancer Screening Who, When, Why

Lung Cancer Screening Who, When, Why Lung Cancer Screening Who, When, Why Louis Kuritzky, MD Clinical Assistant Professor Emeritus Department of Community Health and Family Medicine University of Florida, Gainesville (352) 377 3193 Phone/FAX

More information

The status of Lung Cancer Screening Guidelines. Peter B. Bach, MD, MAPP Memorial Sloan Kettering Cancer Center

The status of Lung Cancer Screening Guidelines. Peter B. Bach, MD, MAPP Memorial Sloan Kettering Cancer Center The status of Lung Cancer Screening Guidelines Peter B. Bach, MD, MAPP Memorial Sloan Kettering Cancer Center bachp@mskcc.org @peterbachmd Homogeneity of guidelines But what about these? Outside the box

More information

Screening for Lung Cancer: New Guidelines, Old Problems

Screening for Lung Cancer: New Guidelines, Old Problems Screening for Lung Cancer: New Guidelines, Old Problems Robert Schilz DO, PhD Associate Professor of Medicine Interim Chief of the Division of Pulmonary, Critical Care and Sleep Medicine University Hospitals

More information

Lung Cancer Screening:

Lung Cancer Screening: Lung Cancer Screening: Maximizing Gain and Dealing with Pandora s Box Mark M. Fuster, MD Division of Pulmonary & Critical Care UCSD Department of Medicine & VA San Diego Healthcare Service San Diego, CA

More information

Emerging Challenges in Primary Care: Lung Cancer Screening: Who, When, Why Or Why Not? Objectives. Faculty

Emerging Challenges in Primary Care: Lung Cancer Screening: Who, When, Why Or Why Not? Objectives. Faculty Emerging Challenges in Primary Care: 2017 Lung Cancer Screening: Who, When, Why Or Why Not? Louis Kuritzky, MD Clinical Assistant Professor Emeritus Department of Community Health and Family Medicine University

More information

Lung Cancer Screening In High Risk Populations:

Lung Cancer Screening In High Risk Populations: Lung Cancer Screening In High Risk Populations: Michael Jaklitsch, M.D. Co-Chair of AATS Task Force on Lung Cancer Screening and Surveillance From the Brigham and Women s Hospital Harvard Medical School.

More information

NCCN Guidelines as a Model of Extended Criteria for Lung Cancer Screening

NCCN Guidelines as a Model of Extended Criteria for Lung Cancer Screening 444 Original Research NCCN Guidelines as a Model of Extended Criteria for Lung Cancer Screening Brady J. McKee, MD; Shawn Regis, PhD; Andrea K. Borondy-Kitts, MS, MPH; Jeffrey A. Hashim, MD; Robert J.

More information

NC I CCC. A Comprehensive Cancer Center Designated by the National Cancer Institute

NC I CCC. A Comprehensive Cancer Center Designated by the National Cancer Institute NC I CCC A Comprehensive Cancer Center Designated by the National Cancer Institute The Controversy About Lung Cancer Screening David S. Ettinger, M.D., FACP, FCCP Alex Grass Professor of Oncology The Sidney

More information

Current Approach to Screening for Lung Cancer. James R Jett M.D.

Current Approach to Screening for Lung Cancer. James R Jett M.D. Current Approach to Screening for Lung Cancer James R Jett M.D. Potential Conflicts of Interest I am Chief Medical Officer for Oncimmune Ltd (Biomarkers of Cancer) Co-Editor of Lung Cancer Section of UP-TO-DATE

More information

Open Access Review Article DOI: /cureus.589. Joshua Dajac 1, Jay Kamdar 1, Austin Moats 2, Brenda Nguyen 1

Open Access Review Article DOI: /cureus.589. Joshua Dajac 1, Jay Kamdar 1, Austin Moats 2, Brenda Nguyen 1 Open Access Review Article DOI: 10.7759/cureus.589 To Screen or not to Screen: Low Dose Computed Tomography in Comparison to Chest Radiography or Usual Care in Reducing Morbidity and Mortality from Lung

More information

Charles Mulligan, MD, FACS, FCCP 26 March 2015

Charles Mulligan, MD, FACS, FCCP 26 March 2015 Charles Mulligan, MD, FACS, FCCP 26 March 2015 Review lung cancer statistics Review the risk factors Discuss presentation and staging Discuss treatment options and outcomes Discuss the status of screening

More information

PANEL DISCUSSION: SCREENING FOR LUNG CANCER. Anthony D Weaver MD

PANEL DISCUSSION: SCREENING FOR LUNG CANCER. Anthony D Weaver MD PANEL DISCUSSION: SCREENING FOR LUNG CANCER Anthony D Weaver MD Disclosures Anthony Weaver has no relationships to disclose. Thank God! A panel of experts! An Equal Opportunity University Objectives 1.

More information

CT Lung Screening Implementation Challenges: State Based Initiatives

CT Lung Screening Implementation Challenges: State Based Initiatives CT Lung Screening Implementation Challenges: State Based Initiatives Andrea McKee, MD Chair Radiation Oncology Lahey Hospital and Medical Center Co-Director Rescue Lung, Rescue Life Program Co-Chair Massachusetts

More information

Veterans Health Administration Lung Cancer Screening Demonstration Project: Results & Lessons Learned

Veterans Health Administration Lung Cancer Screening Demonstration Project: Results & Lessons Learned Veterans Health Administration Lung Cancer Screening Demonstration Project: Results & Lessons Learned Jane Kim, MD, MPH Acting Chief Consultant for Preventive Medicine National Center for Health Promotion

More information

Clinical Policy Title: Lung cancer screening

Clinical Policy Title: Lung cancer screening Clinical Policy Title: Lung cancer screening Clinical Policy Number: 07.01.02 Effective Date: July 1, 2016 Initial Review Date: April 27, 2016 Most Recent Review Date: March 6, 2018 Next Review Date: March

More information

Role of CT in Lung Cancer Screening: 2010 Stuart S. Sagel, M.D.

Role of CT in Lung Cancer Screening: 2010 Stuart S. Sagel, M.D. Role of CT in Lung Cancer Screening: 2010 Stuart S. Sagel, M.D. Lung Cancer 219,440 new cases/year in U.S. (2009) 169,390 deaths/year in U.S. mortality greater than from breast, colon, prostate CA combined

More information

Page 1. Controversies in Cancer Prevention and Screening. Disclosures. Screening. Principles of Screening. I have no conflicts of interest

Page 1. Controversies in Cancer Prevention and Screening. Disclosures. Screening. Principles of Screening. I have no conflicts of interest Controversies in Cancer Prevention and Screening Disclosures Using the Best Evidence in 2015 I have no conflicts of interest Judith M.E. Walsh, MD, MPH Division of General Internal Medicine Women s Health

More information

Lung Cancer Screening

Lung Cancer Screening Lung Cancer Screening v Lung Cancer: America s leading cancer killer Annual US cancer mortality 158,040 221,000 new diagnoses in US 4,100 14,180 27,540 Lung 40,560 40,730 49,700 Cervix Ovary Prostate Pancreas

More information

CT Lung Screening Implementation Challenges: ALA/ATS Implementation Microsite

CT Lung Screening Implementation Challenges: ALA/ATS Implementation Microsite CT Lung Screening Implementation Challenges: ALA/ATS Implementation Microsite Andrea McKee, MD Chair Radiation Oncology Lahey Hospital and Medical Center November 2018 2016 data, 3 years after ACS recommendation

More information

Introduction and Background

Introduction and Background CT Lung Cancer Screening and the Medical Physicist: Background, Findings and Participant Dosimetry Summary of the National Lung Screening Trial (NLST) Randell Kruger, PhD, DABR Medical Physics Section

More information

Patient Decision Aid. Summary Guide for Clinicians. Clinician s Checklist

Patient Decision Aid. Summary Guide for Clinicians. Clinician s Checklist U.S. Department of Health & Human Services About Us Careers Contact Us Español FAQ Email Updates Effective Health Care Home / Decision Aids / Lung Cancer Screening Tools Patient Decision Aid Summary Guide

More information

Lung Cancer Screening in the Midwest of the US: When Histoplasmosis Complicates the Picture

Lung Cancer Screening in the Midwest of the US: When Histoplasmosis Complicates the Picture Cronicon OPEN ACCESS EC PULMONOLOGY AND RESPIRATORY MEDICINE Case Report Lung Cancer Screening in the Midwest of the US: When Histoplasmosis Complicates the Picture Swan Lee 1 and Rolando Sanchez Sanchez

More information

Equity Issues with Lung Cancer Screening Prevent Cancer - Quantitative Imaging Workshop November 5-6, 2018 Alexandria, VA

Equity Issues with Lung Cancer Screening Prevent Cancer - Quantitative Imaging Workshop November 5-6, 2018 Alexandria, VA Equity Issues with Lung Cancer Screening Prevent Cancer - Quantitative Imaging Workshop November 5-6, 2018 Alexandria, VA Mary Pasquinelli, MS, APRN, FNP-BC Pulmonary and Thoracic Medical Oncology Director,

More information

Screening for Lung Cancer. Michael S. Nolledo, MD Deborah Heart and Lung Center

Screening for Lung Cancer. Michael S. Nolledo, MD Deborah Heart and Lung Center Screening for Lung Cancer Michael S. Nolledo, MD Deborah Heart and Lung Center 1 1 Outline Ø Introduction Ø Lung Cancer Screening pre-2010 Ø Lung Cancer Screening today 2 2 Lung Cancer 2011 (Siegel et

More information

Lung Cancer Screening: Now What?

Lung Cancer Screening: Now What? Lung Cancer Screening: Now What? Gerold Bepler, M.D., Ph.D. Director, President & CEO Michigan Cancer Consortium, 2013 Annual Meeting, Lansing, MI, 11/20/13 Lung Cancer #1 Cause of Cancer Death for & *

More information

Screening for Lung Cancer

Screening for Lung Cancer Screening for Lung Cancer 15 ΜΑΡΤΙΟΥ 2014 Ioannis Gkiozos Pulmonologist Oncology Unit G P General & Chest Diseases Hospital Sotiria Despite advances in therapy, 5-year survival rates of Lung Cancer Remains

More information

Will CT screening reduce overall lung cancer mortality? Associate Professor of Radiology Department of Medical Imaging UHN / MSH / WCH

Will CT screening reduce overall lung cancer mortality? Associate Professor of Radiology Department of Medical Imaging UHN / MSH / WCH Will CT screening reduce overall lung cancer mortality? Heidi Roberts MD FRCP(C) Heidi Roberts, MD, FRCP(C) Associate Professor of Radiology Department of Medical Imaging UHN / MSH / WCH Screening - Requirements

More information

Diagnosis and Staging of Non-Small Cell Lung Cancer Carlos Eduardo Oliveira Baleeiro, MD. November 18, 2017

Diagnosis and Staging of Non-Small Cell Lung Cancer Carlos Eduardo Oliveira Baleeiro, MD. November 18, 2017 Diagnosis and Staging of Non-Small Cell Lung Cancer Carlos Eduardo Oliveira Baleeiro, MD November 18, 2017 Disclosures I do not have a financial interest/arrangement or affiliation with one or more organizations

More information

LUNG CANCER SCREENING Anthony C. Campagna, M.D.

LUNG CANCER SCREENING Anthony C. Campagna, M.D. LUNG CANCER SCREENING 2012 Anthony C. Campagna, M.D. Attending Physician, Pulmonary and Critical Care Medicine Lahey Clinic, Burlington, MA Assistant Clinical Professor of Medicine Harvard Medical School,

More information

Faculty Disclosure. Objectives. Lung Cancer in Kentucky: Improving Patient Outcomes 10/28/16. Lung Cancer Burden in Kentucky

Faculty Disclosure. Objectives. Lung Cancer in Kentucky: Improving Patient Outcomes 10/28/16. Lung Cancer Burden in Kentucky Lung Cancer in Kentucky: Improving Patient Outcomes Faculty Disclosure The presenter and members of the development team do not have any conflicts to report. Celeste T. Worth, MCHES Kentucky Collaborative

More information

Cigna Medical Coverage Policy

Cigna Medical Coverage Policy Cigna Medical Coverage Policy Subject Low-Dose Computed Tomography for Lung Cancer Screening Effective Date... 2/15/2014 Next Review Date... 2/15/2015 Coverage Policy Number... 0007 Table of Contents Coverage

More information

Recommendations on Screening for Lung Cancer 2016

Recommendations on Screening for Lung Cancer 2016 Recommendations on Screening for Lung Cancer 2016 Canadian Task Force on Preventive Health Care (CTFPHC) Putting Prevention into Practice Canadian Task Force on Preventive Health Care Groupe d étude canadien

More information

Lung Cancer Screening: A review of the recommendations Friday, November 11th, 2016 from 11:45 to 12:15. Dr. Tunji Fatoye Dr.

Lung Cancer Screening: A review of the recommendations Friday, November 11th, 2016 from 11:45 to 12:15. Dr. Tunji Fatoye Dr. Lung Cancer Screening: A review of the recommendations Friday, November 11th, 2016 from 11:45 to 12:15 Dr. Tunji Fatoye Dr. Alan Kaplan Conflict of Interest Disclosure: Speaker Name: Alan Kaplan FINANCIAL

More information

Disclosures. Cancer Screening for Women. Topics for today. But what about? What works? What doesn t? I have no conflicts of interest

Disclosures. Cancer Screening for Women. Topics for today. But what about? What works? What doesn t? I have no conflicts of interest Cancer Screening for Women Disclosures What works? What doesn t? I have no conflicts of interest Judith M.E. Walsh, MD, MPH Division of General Internal Medicine Women s Health Center of Excellence University

More information

Robert J. McKenna M.D. Chief, Thoracic Surgery Cedars Sinai Medical Center

Robert J. McKenna M.D. Chief, Thoracic Surgery Cedars Sinai Medical Center You Smoke, You Get Lung Cancer, You Die: Can Screening Change this Paradigm? Robert J. McKenna M.D. Chief, Thoracic Surgery Cedars Sinai Medical Center AATS Saturday 4/28/2012 Cancer Screening Cancer

More information

Page 1. Selected Controversies. Cancer Screening! Selected Controversies. Breast Cancer Screening. ! Using Best Evidence to Guide Practice!

Page 1. Selected Controversies. Cancer Screening! Selected Controversies. Breast Cancer Screening. ! Using Best Evidence to Guide Practice! Cancer Screening!! Using Best Evidence to Guide Practice! Judith M.E. Walsh, MD, MPH! Division of General Internal Medicine! Womenʼs Health Center of Excellence University of California, San Francisco!

More information

Screening High-Risk Populations for Lung Cancer

Screening High-Risk Populations for Lung Cancer ORIGINAL ARTICLE Guideline Recommendations Heidi Roberts, MD,* Cindy Walker-Dilks, MLS, Khalil Sivjee, MD, Yee Ung, MD, Kazuhiro Yasufuku, MD, PhD, Amanda Hey, MD, Nancy Lewis, PhD,# and the Lung Cancer

More information

New Advances in Lung Cancer

New Advances in Lung Cancer New Advances in Lung Cancer Douglas E. Wood, MD, FACS, FRCSEd (ad hom) Professor and Chief Division of Cardiothoracic Surgery Vice-Chair, Department of Surgery Endowed Chair in Lung Cancer Research University

More information

Original Policy Date

Original Policy Date MP 6.01.21 Screening for Lung Cancer Using CT Scanning Medical Policy Section Radiology Issue 12:2013 Original Policy Date 12:2013 Last Review Status/Date Reviewed with literature search/12:2013 Return

More information